1. Home
  2. AVD vs STTK Comparison

AVD vs STTK Comparison

Compare AVD & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Vanguard Corporation ($0.10 Par Value)

AVD

American Vanguard Corporation ($0.10 Par Value)

HOLD

Current Price

$3.19

Market Cap

74.1M

Sector

Industrials

ML Signal

HOLD

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$6.90

Market Cap

538.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVD
STTK
Founded
1969
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
74.1M
538.3M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
AVD
STTK
Price
$3.19
$6.90
Analyst Decision
Strong Buy
Buy
Analyst Count
1
7
Target Price
$12.00
$10.00
AVG Volume (30 Days)
578.0K
1.8M
Earning Date
03-16-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
61.11
53.02
EPS
N/A
N/A
Revenue
$515,114,000.00
$1,000,000.00
Revenue This Year
$8.82
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.05
$0.71
52 Week High
$5.92
$8.33

Technical Indicators

Market Signals
Indicator
AVD
STTK
Relative Strength Index (RSI) 64.42 65.14
Support Level $2.37 $5.81
Resistance Level $3.40 $7.68
Average True Range (ATR) 0.22 0.59
MACD 0.05 0.29
Stochastic Oscillator 91.46 88.54

Price Performance

Historical Comparison
AVD
STTK

About AVD American Vanguard Corporation ($0.10 Par Value)

American Vanguard Corp is a United States-based diversified specialty and agricultural products company. The company is a manufacturer of specialty solutions that develops and markets safe synthetic, biological, and biorational products for agricultural, commercial, and consumer uses. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: